LeadingAge Minnesota Foundation invests $400,000 in 24 workforce grants … Merger targets strengthening assisted living … FCC opens applications for $5M internet pilot program for affordable senior...
More news for Friday, Dec. 2
By
Kimberly Bonvissuto
Dec 02, 2022
Bill targets reform of CMS drug coverage authority in wake of aducanumab decision … FCC moves to improve affordable connectivity program for HUD residents … Partnership launches cybersecurity hub,...
Memory care breakthrough, or yet another false alarm?
By
John O'Connor
Dec 01, 2022
This week’s Alzheimer’s revelation is a hopeful sign, but even under the best possible scenario, much work remains.
Alzheimer’s experts throw support behind experimental drug despite adverse events, deaths
By
Kimberly Bonvissuto
Dec 01, 2022
Alzheimer’s disease experts are throwing their support behind the drug lecanemab, despite reports of two deaths tied to the experimental monoclonal antibody medication.
Lecanemab reduced markers of amyloid in early Alzheimer’s disease
Dec 01, 2022
Moderately less decline was seen in cognition and function at 18 months with lecanemab versus placebo.
Progress made in Alzheimer’s research and lifestyle interventions, NIH says
By
Kimberly Bonvissuto
Nov 30, 2022
The burden of Alzheimer’s disease and related dementias is significant, according to the National Institutes of Health. But scientists have made progress in drug development, lifestyle interventions,...
Second death in trial of experimental Alzheimer’s drug raising concerns
Nov 29, 2022
Doctors suspect that by stripping away amyloid deposits, lecanemab weakens blood vessels and leaves them vulnerable to bleeds.
Lawmakers seek passage of two bills that would help prevent, treat Alzheimer’s
By
Kimberly Bonvissuto
Nov 22, 2022
Two lawmakers are asking for support of two bipartisan bills to ensure the nation has the ability to continue both immediate and long-term planning in its battle against Alzheimer’s disease and related...
Business briefs, Nov. 16
By
Kathleen Steele Gaivin
Nov 16, 2022
Pennant Group seeks new CFO … 329 senior living communities named ‘Caring Stars’ for 2023 … Alzheimer’s Association looking for SNFs, ALFs for Ohio study … Collegeville, PA, assisted living...
A stumbling block on the way to an Alzheimer’s cure
By
Lois A. Bowers
Nov 14, 2022
In a new study, 56% of participants said they were not likely to take part in a trial of a dementia-prevention drug. Senior living may be able to play a role in decreasing that percentage.